James Yaro; Analyst; Goldman Sachs & Company, Inc. Brendan O’Brien; Analyst; Wolfe Research Aidan Hall; Analyst; Keefe, Bruyette & Woods, Inc. Good morning and welcome to the Evercore fourth ...

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business ...

Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

Evercore's Q4 2024 EPS of $3.41 beat the forecast of $3.04. Revenue for the quarter reached $975.33 million, surpassing expectations. Stock price increased by 1.82% in premarket trading after the ...

However, citing its channel checks with senior AI engineers at major hyperscalers, Evercore notes that while DeepSeek offers cost improvements, these are seen as “evolutionary rather than ...

In a report released on February 7, Samir Khanal from Evercore ISI maintained a Hold rating on Regency Centers (REG – Research Report), with a price target of $79.00. The company’s shares ...

In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a price target of $150.00. The company’s shares closed ...

NEW YORK (AP) — NEW YORK (AP) — Evercore Inc. (EVR) on Wednesday reported net income of $140.4 million in its fourth quarter. The company, based in New York, said it had earnings of $3.30 per ...

(RTTNews) - Evercore Inc. (EVR) reported a profit for its fourth quarter that increased from last year and beat the Street estimates. The company's earnings came in at $140.44 million, or $3.30 ...

However, citing its channel checks with senior AI engineers at major hyperscalers, Evercore notes that while DeepSeek offers cost improvements, these are seen as “evolutionary rather than ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...